From real patient stories to tips on living well, hear firsthand from people who have faced blood cancer.
We’ve also got the latest research and advocacy news, as well as stories from our wonderful fundraisers and donors. You can subscribe to our e-newsletters and event news here.
When talking to her patients, clinical haematologist and researcher Associate Professor Nada Hamad always considers their eligibility for a clinical trial.
People with chronic lymphocytic leukaemia (CLL) have a sizeable 600% higher risk of the most dangerous form of skin cancer, melanoma, researchers have found.
Patrick Griffin's overcame prostate cancer, then lymphoma, before being diagnosed with CLL.
Clinical haematologist and researcher, Associate Professor Nada Hamad discusses the latest on CLL.
Getting to know the clinical haematologist and researcher,
Ongoing fatigue was the symptom that prompted Phil Nicholls to have his first medical assessment in years and it resulted in his diagnosis with chronic lymphocytic leukaemia (CLL).
Find out why the clinical haematologist is dedicating his life to CLL.
It’s 10 years since the first CLL patients were treated with CAR T-cell therapy and they are still in remission.
In March 2022, member of the Blood Cancer Taskforce and Cancer Australia's Advisory Council Deborah Henderson found out she had COVID-19. Here, she shares her first-person narrative of that experience.
Delighted, really relieved, and excited was Deborah Henderson’s response to her nine-month review following CAR T-cell therapy last year.
Yael Morris was very young – only 34 years old, 28 weeks pregnant, and living in Darwin – when she was diagnosed with CLL 20 years ago.
Dr Piers Blombery specialises in genomic testing and heads Australia’s largest haematology laboratory.
Associate Professor Michael Dickinson says CAR T-cell therapy is a 'revolutionary step forward'.
All Jane Blakely knew about leukaemia was that "people who have leukaemia die".
Updates on three novel therapies for the treatment of CLL and SLL.
Thirty-one days after Deborah Henderson had an infusion of her own re-engineered T-cells in September, she was told her aggressive CLL was in remission and she may well be cured.
Dr Anderson was one of the key researchers involved in the discovery of the live-changing drug, venetoclax (Venclexta®).
Deborah Henderson kissed her children goodbye and moved to London in the hope of getting on a clinical trial.
We spoke to Professor Con Tam on the latest in CLL research.
This Father’s Day, and every day, we’re celebrating brave Aussie dads like Bill Kuluris, who are living with a blood cancer.
